Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model
Keywords: Clinicla trial design; Glioblastoma; Gbm; High-throughput screening; Novel targeted approach; Personalized therapy; Pharmaco-omics; Pan-omic; Tumor heterogeniety;